BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16839744)

  • 1. Modulation of subfamily B/R4 RGS protein function by 14-3-3 proteins.
    Abramow-Newerly M; Ming H; Chidiac P
    Cell Signal; 2006 Dec; 18(12):2209-22. PubMed ID: 16839744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A key serine for the GTPase-activating protein function of regulator of G protein signaling proteins is not a general target for 14-3-3 interactions.
    Ward RJ; Milligan G
    Mol Pharmacol; 2005 Dec; 68(6):1821-30. PubMed ID: 16160139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.
    Niu J; Scheschonka A; Druey KM; Davis A; Reed E; Kolenko V; Bodnar R; Voyno-Yasenetskaya T; Du X; Kehrl J; Dulin NO
    Biochem J; 2002 Aug; 365(Pt 3):677-84. PubMed ID: 11985497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of palmitoylation in RGS protein function.
    Jones TL
    Methods Enzymol; 2004; 389():33-55. PubMed ID: 15313558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
    Tovey SC; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-tasking RGS proteins in the heart: the next therapeutic target?
    Riddle EL; Schwartzman RA; Bond M; Insel PA
    Circ Res; 2005 Mar; 96(4):401-11. PubMed ID: 15746448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the affinity and selectivity of RGS protein interaction with G alpha subunits by a conserved asparagine/serine residue.
    Posner BA; Mukhopadhyay S; Tesmer JJ; Gilman AG; Ross EM
    Biochemistry; 1999 Jun; 38(24):7773-9. PubMed ID: 10387017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G protein signaling proteins: novel multifunctional drug targets.
    Zhong H; Neubig RR
    J Pharmacol Exp Ther; 2001 Jun; 297(3):837-45. PubMed ID: 11356902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins.
    Fu Y; Zhong H; Nanamori M; Mortensen RM; Huang X; Lan K; Neubig RR
    Methods Enzymol; 2004; 389():229-43. PubMed ID: 15313569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel activity of RGS14 on Goalpha and Gialpha nucleotide binding and hydrolysis distinct from its RGS domain and GDI activity.
    Hepler JR; Cladman W; Ramineni S; Hollinger S; Chidiac P
    Biochemistry; 2005 Apr; 44(14):5495-502. PubMed ID: 15807543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.
    Roy AA; Lemberg KE; Chidiac P
    Mol Pharmacol; 2003 Sep; 64(3):587-93. PubMed ID: 12920194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric regulation of GAP activity by phospholipids in regulators of G-protein signaling.
    Tu Y; Wilkie TM
    Methods Enzymol; 2004; 389():89-105. PubMed ID: 15313561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion proteins as model systems for the analysis of constitutive GPCR activity.
    Schneider EH; Seifert R
    Methods Enzymol; 2010; 485():459-80. PubMed ID: 21050932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking.
    Zheng B; Ma YC; Ostrom RS; Lavoie C; Gill GN; Insel PA; Huang XY; Farquhar MG
    Science; 2001 Nov; 294(5548):1939-42. PubMed ID: 11729322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits.
    Watson N; Linder ME; Druey KM; Kehrl JH; Blumer KJ
    Nature; 1996 Sep; 383(6596):172-5. PubMed ID: 8774882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence-based assays for RGS box function.
    Willard FS; Kimple RJ; Kimple AJ; Johnston CA; Siderovski DP
    Methods Enzymol; 2004; 389():56-71. PubMed ID: 15313559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and in vitro functional analysis of R7 subfamily RGS proteins in complex with Gbeta5.
    Hooks SB; Harden TK
    Methods Enzymol; 2004; 390():163-77. PubMed ID: 15488177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.
    Roman DL; Talbot JN; Roof RA; Sunahara RK; Traynor JR; Neubig RR
    Mol Pharmacol; 2007 Jan; 71(1):169-75. PubMed ID: 17012620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of Ser166 in RGS5 by protein kinase C causes loss of RGS function.
    Moroi K; Nishiyama M; Kawabata S; Ichiba H; Yajima T; Kimura S
    Life Sci; 2007 Jun; 81(1):40-50. PubMed ID: 17540411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.